Skip to main content
Dual agonist proteins for the treatment of type 2 diabetes

Dual agonist proteins for the treatment of type 2 diabetes

Unmet Need Over 37 million people in the United States have diabetes, and approximately 90-95% of them have type 2 diabetes (T2D). Diabetes and its related complications not only cause premature mortality and lower quality…

Read More

A peptide therapy for diabetes that improves islet cell mass and function

A peptide therapy for diabetes that improves islet cell mass and function

Methods of modulating blood glucose levels treating hyperglycemia and related complications and conditions by administration of a VGF biomolecule to a patient in need of such treatment are provided. Methods of enhancing insulin secretion from…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us